Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Annual Meeting & Proxy Information

Annual Meeting & Proxy InformationSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

The 2013 annual meeting of stockholders of Spectrum Pharmaceuticals, Inc. was held at our Henderson, Nevada corporate headquarters located at 11500 South Eastern Ave., Suite 240, Henderson, Nevada 89052, on Friday, June 28, 2013, at 10:30 a.m., Pacific Time. Links to the Proxy Materials are provided below.

Title Type Size  
2013 Proxy Statement PDF 2.5 MB Add to Briefcase
Schedule 14A CS Notice PDF 420.4 KB Add to Briefcase
Schedule 14A Broker Notice PDF 281.9 KB Add to Briefcase
2012 Annual Report PDF 2.3 MB Add to Briefcase
Add to Briefcase = add file to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
6.90
Change:
+ 0.21
Day High:
7.02
Day Low:
6.68
Volume:
856,600
4:00 PM ET on Apr 22, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company